Search results for “Diabetic cardiomyopathy” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 411 patents, we discovered top 44 key players by total patent application. Pfizer Products, Inc., Novartis AG, Pfizer Inc. are dominant in this area. They take 66.67% of the total patent filing.
Pfizer Products, Inc.
Connecticut, United States
Patent: 170
Novartis AG
Basel-Stadt, Switzerland
Patent: 55
Pfizer Inc.
New York, United States
Patent: 49
Sanofi-Aventis Deutschland GmbH
Hessen, Germany
Patent: 22
Ampsource Biopharma Shanghai Inc.
Shanghai Shi, China
Patent: 11
Applied Therapeutics, Inc.
New York, United States
Patent: 9
REMD Biotherapeutics, Inc.
California, United States
Patent: 9
Shanghai Hansoh Biomedical Co. Ltd.
Shanghai Shi, China
Patent: 9
Jiangsu Hansoh Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 9
AstraZeneca Pharmaceuticals LP
Delaware, United States
Patent: 8
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 2
STARTUP
Noden Pharma DAC
DUBLIN, Ireland
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 94 patents applied in the last 5 years. We discover 49 most active companies in this area. The fast-growing Ampsource Biopharma Shanghai Inc., The Trustees of Columbia University in The City of New York, Applied Therapeutics, Inc. take 30.85% of patent filing during this period.
Ampsource Biopharma Shanghai Inc.
Shanghai Shi, China
Patent: 11
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 9
Applied Therapeutics, Inc.
New York, United States
Patent: 9
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 4
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 3
Guangzhou Medical University
Guangdong Sheng, China
Patent: 3
Wuhan University
Hubei Sheng, China
Patent: 3
Tongji Hospital Tongji Medical College of HUST
Hubei Sheng, China
Patent: 3
NHC Communications, Inc.
Canada
Patent: 3
The Second Affiliated Hospital of Nanchang University
China
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 94 patents in last 5 years, we discover 40 new entrants. Ampsource Biopharma Shanghai Inc., Applied Therapeutics, Inc., Glaxosmithkline Intellectual Property Development Ltd. are the most active new entrants in this area.
Ampsource Biopharma Shanghai Inc.
Shanghai Shi, China
Patent: 11
Applied Therapeutics, Inc.
New York, United States
Patent: 9
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 4
Wuhan University
Hubei Sheng, China
Patent: 3
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 3
Guangzhou Medical University
Guangdong Sheng, China
Patent: 3
NHC Communications, Inc.
Canada
Patent: 3
The Second Affiliated Hospital of Nanchang University
China
Patent: 2
Jiangxi Normal University
Jiangxi Sheng, China
Patent: 2
Shenzhen University General Hospital
undefined undefined
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 77 patents, we discovered top 28 universities and scientific research institutions by total patent application. The Trustees of Columbia University in The City of New York, University of Rochester, China Pharmaceutical University are dominant in this area. They take 32.47% of the total patent filing.
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 17
University of Rochester
New York, United States
Patent: 5
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 3
Wenzhou Medical College
Zhejiang Sheng, China
Patent: 3
Wuhan University
Hubei Sheng, China
Patent: 3
Guangzhou Medical University
Guangdong Sheng, China
Patent: 3
Jilin University
Jilin Sheng, China
Patent: 2
Guangdong Medical University
Guangdong Sheng, China
Patent: 2
Jiangxi Normal University
Jiangxi Sheng, China
Patent: 2
Washington University in St. Louis
Missouri, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: